Analyst Ratings for Cadrenal Therapeutics (CVKD)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/18/2023 | Noble Capital | Robert LeBoyer | New Coverage | Outperform (N/A) |
4.00 (N/A) |
0.51 (8.28) |
1523.53% | Details |
| 11/20/2023 | H.C. Wainwright » Updated 11/11/2024 |
Joseph Pantginis | New Coverage | Buy (N/A) |
32.00 (3.00) |
0.47 (8.28) |
1661.7% | Details |
